PL432842A1 - LPS for use in inducing tolerance in an individual to food allergens causing IgE-mediated food allergies - Google Patents

LPS for use in inducing tolerance in an individual to food allergens causing IgE-mediated food allergies

Info

Publication number
PL432842A1
PL432842A1 PL432842A PL43284220A PL432842A1 PL 432842 A1 PL432842 A1 PL 432842A1 PL 432842 A PL432842 A PL 432842A PL 43284220 A PL43284220 A PL 43284220A PL 432842 A1 PL432842 A1 PL 432842A1
Authority
PL
Poland
Prior art keywords
lps
food
individual
inducing tolerance
mediated
Prior art date
Application number
PL432842A
Other languages
Polish (pl)
Inventor
Ewa Kozłowska
Nadzieja DRELA
Original Assignee
Uniwersytet Warszawski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Warszawski filed Critical Uniwersytet Warszawski
Priority to PL432842A priority Critical patent/PL432842A1/en
Priority to PCT/PL2021/050003 priority patent/WO2021162563A1/en
Publication of PL432842A1 publication Critical patent/PL432842A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Przedmiotem wynalazku jest LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe związane z alergiami pokarmowymi zależnymi od IgE, przy czym stosuje się LPS pochodzący z bakterii E. coli ze szczepu 0111:B4, który podaje się osobnikowi przed kontaktem z alergenem.The invention relates to a LPS for use in inducing tolerance in an individual to food allergens associated with IgE-dependent food allergies, wherein an E. coli LPS derived from the 0111: B4 strain is used which is administered to the subject prior to contact with the allergen.

PL432842A 2020-02-10 2020-02-10 LPS for use in inducing tolerance in an individual to food allergens causing IgE-mediated food allergies PL432842A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL432842A PL432842A1 (en) 2020-02-10 2020-02-10 LPS for use in inducing tolerance in an individual to food allergens causing IgE-mediated food allergies
PCT/PL2021/050003 WO2021162563A1 (en) 2020-02-10 2021-02-10 Lipopolysaccharides for treating food allergies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL432842A PL432842A1 (en) 2020-02-10 2020-02-10 LPS for use in inducing tolerance in an individual to food allergens causing IgE-mediated food allergies

Publications (1)

Publication Number Publication Date
PL432842A1 true PL432842A1 (en) 2021-08-16

Family

ID=75439422

Family Applications (1)

Application Number Title Priority Date Filing Date
PL432842A PL432842A1 (en) 2020-02-10 2020-02-10 LPS for use in inducing tolerance in an individual to food allergens causing IgE-mediated food allergies

Country Status (2)

Country Link
PL (1) PL432842A1 (en)
WO (1) WO2021162563A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000042994A2 (en) * 1999-01-21 2000-07-27 North Shore-Long Island Jewish Research Institute Inhibition of bacterial dissemination
DE10013539B4 (en) * 2000-03-20 2006-07-13 Pharma-Zentrale Gmbh Escherichia coli lipopolysaccharides, process for their preparation and their uses
DE10125179A1 (en) * 2001-05-23 2002-12-05 Laves Ralph Georg Use of LPS to treat intestinal inflammatory processes
US8563523B2 (en) * 2007-09-07 2013-10-22 University Of Georgia Research Foundation, Inc. Synthetic lipid A derivative

Also Published As

Publication number Publication date
WO2021162563A1 (en) 2021-08-19

Similar Documents

Publication Publication Date Title
CY1126103T1 (en) SOLID FORMS AND PHARMACEUTICAL FORMS OF (S)-4-(8-AMINO-3-(l-(BOYT-2-YNOYL)PYPPOLIDIN-2-YLO)IMIDAZO[1,5-A]PYZIN-1-YL)- N-(PYRIDIN-2-YL)BENZAMIDO
MX2022008663A (en) MIXED ALLERGENIC COMPOSITIONS AND METHODS OF USE THEREOF.
ES2571856T3 (en) Use of nutritional compositions to prevent visceral adiposity
AR109170A2 (en) ACID SPHINGOMYELINASE FOR USE IN THE PREVENTION OR TREATMENT OF NIEMANN-PICK A OR B DISEASE IN A PATIENT
CO2019011847A2 (en) Improved pea albumins, method of obtaining them and their applications
MX2018004715A (en) Composition comprising a mixture of molecules extracted from chrysanthellum indicum, cynara scolymus and lycium barbarum and use to act on carbohydrate and/or fat metabolism.
BR112019014397A2 (en) COMPOSITIONS OF NEISSERIA MENINGITIDIS AND METHODS OF THE SAME
BR112017003948A2 (en) composition
MX2017010576A (en) MALTOOLIGOSACARIDS RICH IN FIBER THAT HAVE LOW BIODISPONIBILITY OF GLUCOSE, PROCEDURE FOR MANUFACTURING THEMSELVES AND USE OF THE SAME IN FOODS FOR HUMANS AND FEEDS FOR ANIMALS.
ECSP23029634A (en) BACILLUS PROBIOTIC COMPOSITIONS AND METHODS OF USE
MX2021005465A (en) Nutrition bar for intermittent fasting-mimicking.
Wau et al. Levels of Stress Related to Incidence of Gastritis in Adolescents
Chatain et al. Medicinal bioactivites and allergenic properties of pumpkin seeds: review upon a pediatric food anaphylaxis case report
BR112018013501A2 (en) use of a fermented ingredient and nondigestible oligosaccharide in the manufacture of a nutritional composition, method for enhancing immunoglobulin a secretion in a human subject aged 0 to 36, and method for enhancing mucosal immune defense in a human subject aged 0 to 36 months
EA201990420A1 (en) DEVICE FOR MASSAGE WITH STIMULATING ELEMENT, METHOD OF ITS APPLICATION AND METHOD OF ITS MANUFACTURE
DE60109180D1 (en) PARIETARIA JUDAICA NS-LTP ANTIGEN VARIANTS, CORRESPONDING PHARMACEUTICAL COMPOSITIONS AND THEIR USE
WO2006014907A3 (en) Use of parasitic biological agents for prevention and control of allergic and other ige-mediated disorders
Inoue et al. A survey comparing the route of HIV transmission reported by patients to their physicians and the self-reported" actual route"
WO2009104184A3 (en) Extracts of sclerocarya birrea
Yazdanbakhsh et al. Parasitic infection: good or bad for the hygiene hypothesis?
Jeon et al. A case of latex-fruit syndrome in a patient with latex anaphylaxis
Hajavi et al. Investigating Food Allergy Frequency Among Native Population and University Students in Gonabad
AU2001266983A1 (en) Adjuvants and processes to induce a specific type of immune response
Kolesnikova Clinical and immunological efficacy of muramyldipeptide (GMDP) in fertility disorders (scientific review)
NADIA et al. DENTAL PRACTITIONERS AND THEIR PERCEPTIONS REGARDING THE USE OF ANTIOXIDANTS IN THE PROMOTION OF ORAL HEALTH